| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dror Ortho-Design, Inc. | Director | Common Warrants | 42,417,309 | 14 Aug 2023 | Indirect | ||
| Dror Ortho-Design, Inc. | Director | Stock Option (Right to Buy) | 21,122,239 | 17 Jun 2024 | Direct | ||
| Dror Ortho-Design, Inc. | Director | Series A Convertible Preferred Stock | 592,151 | 14 Aug 2023 | Indirect | ||
| NRX Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25,000 | 09 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | 09 Apr 2025 | 1 | $0 | 4 | Director | 10 Sep 2025, 15:35 |
| DROR | Dror Ortho-Design, Inc. | 17 Jun 2024 | 1 | +$78,152 | 4 | Director | 25 Jun 2024, 17:27 |
| NRXP | NRX Pharmaceuticals, Inc. | 30 Aug 2023 | 1 | +$20,125 | 4 | Director | 11 Sep 2023, 09:15 |
| DROR | Dror Ortho-Design, Inc. | 14 Aug 2023 | 2 | $0 | 4 | Director | 27 Sep 2023, 21:33 |
| NRXP | NRX Pharmaceuticals, Inc. | 21 Oct 2022 | 3 | +$514,905 | 4/A | Director | 23 Nov 2022, 15:09 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 3 | $0 | 4 | Director | 10 Jun 2021, 18:47 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 0 | $0 | 3 | Director | 10 Jun 2021, 18:32 |